Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2020-03-11 AGM Information
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Seegene Inc. It contains the agenda for the annual general meeting, including financial statement approval, director appointments, and remuneration limits. It also includes detailed management information, business overviews, and financial statements (balance sheet, income statement) as part of the meeting materials provided to shareholders. This type of document is a standard proxy statement/information circular for an AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Seegene. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda items for their vote. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2020-03-06 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted by Seegene to explain why their Annual General Meeting (AGM) is being held on a 'concentrated' date (a date when many other companies are also holding meetings). It provides the date of the meeting, the reason for the scheduling conflict, and references the KOSDAQ Association's voluntary compliance program. Since this is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2020-03-06 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Seegene regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend record date, the total dividend amount, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2020-03-06 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 95% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) meeting scheduled for February 27-28, 2020. It outlines the logistics, purpose (business status update), and target audience (institutional investors). Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Investor Presentation', it falls under the general regulatory announcement category.
2020-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Seegene regarding a significant change (over 15%) in revenue or profit structure. It provides a summary table of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous one, along with the reasons for the change. This is a standard 'Earnings Release' (ER) filing, which is an initial announcement of financial results rather than a full annual report or a mere publication notice. FY 2019
2020-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.